Clinical trial
Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population
NCT04270201 is registered in ClinicalTrials.gov with Instituto do Cancer do Estado de São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of ALDH1b1 and ALDH2 Polymorphisms Frequency in the Brazilian Population
- Lead sponsor
- Instituto do Cancer do Estado de São Paulo
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 2, 2022
- Completion date
- December 1, 2023
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral squamous cell carcinoma (oscc)